|
|
Volumn 2, Issue 4, 2001, Pages 301-308
|
|
Organ transplant-related lymphoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTIVIRUS AGENT;
MONOCLONAL ANTIBODY;
ADOPTIVE IMMUNOTHERAPY;
ADULT;
CHILD;
DISEASE TRANSMISSION;
EPIDEMIOLOGY;
EPSTEIN BARR VIRUS;
GROWTH, DEVELOPMENT AND AGING;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
NONHODGKIN LYMPHOMA;
POSTOPERATIVE COMPLICATION;
REMISSION;
REVIEW;
RISK;
TRANSPLANTATION;
TREATMENT OUTCOME;
VIROLOGY;
VIRUS ACTIVATION;
VIRUS INFECTION;
ADULT;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ANTIVIRAL AGENTS;
CHILD;
EPIDEMIOLOGIC METHODS;
EPSTEIN-BARR VIRUS INFECTIONS;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMUNOCOMPROMISED HOST;
IMMUNOSUPPRESSION;
IMMUNOTHERAPY, ADOPTIVE;
INCIDENCE;
LYMPHOMA, NON-HODGKIN;
POSTOPERATIVE COMPLICATIONS;
REMISSION INDUCTION;
RISK;
TRANSPLANTATION;
TREATMENT OUTCOME;
VIRUS ACTIVATION;
|
|
EID: 0035436864
PISSN: 15272729
EISSN: None
Source Type: Journal
DOI: 10.1007/s11864-001-0023-7 Document Type: Review |
|
Times cited : (21)
|
|
References (29)
|
